`Tel: 571.272.7822
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________
`
`PRAXAIR DISTRIBUTION, INC..
`Petitioner
`
`v.
`
`INO THERAPEUTICS, LLC
`Patent Owner
`
`_____________
`
`Case IPR2015-00891
`Patent 8,573,210
`_____________
`
`PETITIONER’S UPDATED EXHIBIT LIST
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-00891
`Patent 8,573,210
`
`
`Updated List of Exhibits
`
`Ex. 1001 U.S. Patent No. 8,573,210 (“’210 Patent”).
`
`Ex. 1002 Declaration of Robert T. Stone, Ph.D.
`
`Ex. 1003 Curriculum Vitae of Robert T. Stone, Ph.D.
`
`Ex. 1004 U.S. Patent No. 7,114,510 (“’510 Patent”), filed May 15, 2003, issued
`
`October 3, 2006.
`
`Ex. 1005 U.S. Patent No. 5,558,083 (“’083 Patent”), filed November 22, 1993,
`
`issued September 24, 1996.
`
`Ex. 1006
`
`French Publication No. 2 917 804 (“FR ’804 Publication”), published
`
`December 26, 2008.
`
`Ex. 1007
`
`ISO/IEEE 11073-30300, “Health informatics -- Point-of-care medical
`
`device communication -- Part 30300: Transport profile -- Infrared
`
`wireless,” ISO, IEEE, published December 15, 2004 (“IR Standard”).
`
`Ex. 1008 U.S. Patent No. 6,811,533 (“’533 Patent”), filed January 22, 2001,
`
`issued November 2, 2004.
`
`Ex. 1009 Assignment History of the ’083 Patent.
`
`Ex. 1010 U.S. Patent No. 4,462,398 (“’398 Patent”), filed December 3, 1982,
`
`issued July 31, 1984.
`
`Ex. 1011 Air Liquide Opti KINOX Brochure, dated 2009.
`
`Ex. 1012
`
`“Guidance Document for Premarket Notification Submissions for
`
`1
`
`
`
`Case IPR2015-00891
`Patent 8,573,210
`
`
`Nitric Oxide Delivery Apparatus, Nitric Oxide Analyzer and Nitrogen
`
`Dioxide Analyzer,” (“FDA Guidance”) document issued January 24,
`
`2000 by the U.S. Department of Health and Human Services, Food
`
`and Drug Administration.
`
`Ex. 1013 U.S. Patent No. 4,308,865 (“’865 Patent”), filed October 19, 1979,
`
`issued January 5, 1982.
`
`Ex. 1014 Center for Drug Evaluation and Research, Application Number: NDA
`
`20845, INOMAX®, Final Printed Labeling, (“INOMAX Label”)
`
`available at http://www.accessdata.fda.gov/drugsatfda_
`
`docs/nda/99/20845_inomax_prntlbl.pdf (August 9, 2000).
`
`Ex. 1015 Reserved
`
`Ex. 1016 Reserved
`
`Ex. 1017
`
`Prosecution History of U.S. Patent No. 8,573,210.
`
`Ex. 1018 Reserved
`
`Ex. 1019 Reserved
`
`Ex. 1020 Declaration of translator Claudine Joly-King under 28 U.S.C. § 1746
`
`regarding Ex. 1006.
`
`2
`
`
`
`
`
`
`
`Certification of Service
`
`A copy of this Updated Exhibit List has been served on counsel for Patent
`
`Owner on September 8, 2015 at the following email addresses:
`
`Dominick A. Conde - dconde@fchs.com
`Edmund J. Haughey - ehaughey@fchs.com
`
`By:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Sanjay K. Murthy/
`Reg. No. 45,976
`Sanjay K. Murthy
`Customer No. 24573
`K&L Gates LLP
`e-mail: sanjay.murthy@klgates.com
`telephone number: 312-807-4416
`fax number: 312-827-8138
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`
`
`
`
`
`Date: September 8, 2015